Reig Jofre has announced a €30 million investment and the triplication of the productive capacity of its Barcelona plant. The pharmaceutical group, a member of CataloniaBio & HealthTech, informs the project will imply the construction of a new building provided with state-of-the-art technologies for the manufacture of lyophilized vials and liquid vials.
It will also increase the aseptic production capacity, and will enable addressing the development and manufacture of innovative and biosimilars products (it has created the joint venture Syna Therapeutics with the biotechnology company Leanbio).
The new building for liquid and freeze-dried vials will be built inside the injectable products plant, with an area of 2,500 square metres. Total production will exceed 50 million vials, when the plant operates at full capacity, compared to the current 15 million.
CEO Ignasi Biosca explained during a meeting with investors that the company spent €8,1 million last year on R&D.
The project is expected to be completed by 2020.
Photo: Plant in Sant Joan Despí (Barcelona) - © Reig Jofre
Comments